| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/05/2011 | CA2543928C Optimized expression of hpv 58 l1 in yeast |
| 04/05/2011 | CA2445162C Estrogen dependent transactivation system for gender sorting in avian species |
| 04/05/2011 | CA2429027C Antibodies against human receptor h4-1bb |
| 04/05/2011 | CA2402186C Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 04/05/2011 | CA2309355C Tissue cement proteins from rhipicephalus appendiculatus |
| 04/05/2011 | CA2300854C Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 04/05/2011 | CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/31/2011 | WO2011038394A2 Silk fibroin-decorin scaffolds |
| 03/31/2011 | WO2011038368A1 Genetic manipulation of the at-hook domain in plant ahl genes to modulate cell growth |
| 03/31/2011 | WO2011038219A1 Proteases having improved stability, solubility and activity |
| 03/31/2011 | WO2011038205A2 Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh |
| 03/31/2011 | WO2011038149A2 Methods of treating inflammation |
| 03/31/2011 | WO2011038133A2 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 03/31/2011 | WO2011036564A2 Hyperblebbing shigella strains |
| 03/31/2011 | WO2011036563A2 Structure of the n-rna complex of the non-segmented negative-strand rna viruses of the paramyxoviridae family |
| 03/31/2011 | WO2011036536A2 Inactivated microorganisms containing double -strand rna molecules (dsrna), their use as pesticides and methods for their preparation |
| 03/31/2011 | WO2011036450A2 Splice variants |
| 03/31/2011 | WO2011036444A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 03/31/2011 | WO2011036443A2 Polypeptides and uses thereof |
| 03/31/2011 | WO2011036442A2 Polypeptides and uses thereof |
| 03/31/2011 | WO2011036440A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | WO2011036240A1 Variants of stat transcription factors having improved dna bonding |
| 03/31/2011 | WO2011036211A1 Polypeptides and nucleic acids for treating erbb2-dependent cancers |
| 03/31/2011 | WO2011036174A1 A novel method for the production of a antimicrobial peptide |
| 03/31/2011 | WO2011036160A1 Plants having enhanced yield-related traits and a method for making the same |
| 03/31/2011 | WO2011035914A1 Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same |
| 03/31/2011 | WO2011035555A1 Comprehensive process and equipment for use of carbonaceous organic matter |
| 03/31/2011 | WO2011035456A1 Method of acquiring proteins with high affinity by computer aided design |
| 03/31/2011 | WO2011035423A1 Method of preparing plant-derived proteins |
| 03/31/2011 | WO2011035386A1 Cation channel activity |
| 03/31/2011 | WO2011017159A3 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 03/31/2011 | WO2011011797A3 Cytokine compositions and methods of use thereof |
| 03/31/2011 | WO2011008641A8 Methods of modulating angiogenesis and treatment of angiogenesis-related diseases |
| 03/31/2011 | WO2011006982A3 Masp isoforms as inhibitors of complement activation |
| 03/31/2011 | WO2010149752A3 Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease |
| 03/31/2011 | WO2010141133A3 Silk fibroin systems for antibiotic delivery |
| 03/31/2011 | WO2010139469A3 Antibodies against human ccn1 and uses thereof |
| 03/31/2011 | WO2010136897A3 Luxr mutants from vibrio fischeri auto induction expression systems using them |
| 03/31/2011 | WO2010133543A3 Process to produce a wine or fruit juice stabiliser |
| 03/31/2011 | WO2010128285A3 Method of modifying serine protease inhibitors |
| 03/31/2011 | WO2010124256A3 Methods and systems for identifying immunomodulatory substances |
| 03/31/2011 | WO2010118169A3 Human protein scaffold with controlled serum pharmacokinetics |
| 03/31/2011 | WO2010108005A3 Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
| 03/31/2011 | WO2010106127A3 Method for therapeutic use |
| 03/31/2011 | WO2010093802A3 Therapeutic method for increasing pancreatic beta cell mass |
| 03/31/2011 | WO2010080909A9 Compositions and methods of use of an oncolytic vesicular stomatitis virus |
| 03/31/2011 | WO2010064132A8 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation |
| 03/31/2011 | WO2010030861A3 Compositions and methods for purifying calreticulin |
| 03/31/2011 | WO2010029317A3 Treating inflammatory conditions |
| 03/31/2011 | US20110078831 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/31/2011 | US20110078829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/31/2011 | US20110078828 Multi epitope vaccine for poultry |
| 03/31/2011 | US20110078826 Yield enhancement in plants by modulation of a zm-eref-ts protein |
| 03/31/2011 | US20110077384 Protein refolding method |
| 03/31/2011 | US20110077382 Collagen Peptide Having Immune-enhancing Activity from Cyanea Nozakii and Preparation Method and Uses Thereof |
| 03/31/2011 | US20110077287 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions |
| 03/31/2011 | US20110077210 Hdac regulation assays, compounds and therapeutic compositions |
| 03/31/2011 | US20110077209 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077207 Method for treating inflammation |
| 03/31/2011 | US20110077206 Use of hnf4alpha for treatment of human malignant solid tumors through induction-differentiation therapy |
| 03/31/2011 | US20110077204 Agent for Targeted Drug Delivery To Cerebral Neurons |
| 03/31/2011 | US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 03/31/2011 | US20110077202 Targeted Coagulation Factors and Method of Using the Same |
| 03/31/2011 | US20110077197 Novel insulin derivatives having an extremely delayed time-action profile |
| 03/31/2011 | US20110077196 Non-standard insulin analogues |
| 03/31/2011 | US20110077192 Novel Antibacterial Peptides |
| 03/31/2011 | US20110077170 Hpiv-2 variants and their medical applications |
| 03/31/2011 | US20110076778 Solubilization of proteins in reverse micelles by extraction from a solid support |
| 03/31/2011 | US20110076704 Method for diagnosing alzheimer's disease using serum glycoprotein as biomarker |
| 03/31/2011 | US20110076699 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum |
| 03/31/2011 | US20110076696 Cardiovascular safety assay |
| 03/31/2011 | US20110076693 Method for detection and quantification of plk1 expression and activity |
| 03/31/2011 | US20110076382 Aqueous plant protein preparation and method for producing the same |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076302 Plant-derived vaccines against respiratory syncytial virus |
| 03/31/2011 | US20110076301 Antigenic protein fragments of streptococcus pneumoniae |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076298 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 03/31/2011 | US20110076289 Transgenic animal model of neurodegenerative disorders |
| 03/31/2011 | US20110076288 Compositions for and Methods of Identifying Antigens |
| 03/31/2011 | US20110076277 Methods of identifying anti-inflammatory compounds |
| 03/31/2011 | US20110076264 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 03/31/2011 | US20110076248 Immunizing compositions comprising hiv-1 proviral constructs with an inactive p6 gag tsg101 uev binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface. |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | CA2775642A1 Hyperblebbing shigella strains |
| 03/31/2011 | CA2775159A1 Method of acquiring proteins with high affinity by computer aided design |
| 03/31/2011 | CA2775012A1 Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same |
| 03/31/2011 | CA2774973A1 Peptidomimetic macrocycles |
| 03/31/2011 | CA2774946A1 Identification of antigenic peptides from multiple myeloma cells |
| 03/31/2011 | CA2774836A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | CA2774612A1 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 03/31/2011 | CA2774296A1 Polypeptides and uses thereof |
| 03/31/2011 | CA2774288A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 03/31/2011 | CA2773978A1 Methods of treating inflammation |
| 03/31/2011 | CA2773949A1 Novel npr-b agonists |
| 03/31/2011 | CA2772983A1 Plants having enhanced yield-related traits and a method for making the same |
| 03/31/2011 | CA2772964A1 Method of preparing plant-derived proteins |
| 03/30/2011 | EP2302075A2 Method for typing of HLA alleles |